Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
For patients using semaglutide for weight management, reduced potency simply means diminished therapeutic benefit rather than acute safety risks
GLP-1
Sustainable, gradual weight loss Nooms microdosing program reports patients losing up to 11 pounds in 30 days and 17 pounds in 60 days
Mounjaro/Zepbound (Tirzepatide) Mounjaro (for diabetes) and Zepbound (for weight loss) contain tirzepatide, a newer medication that acts on both GLP-1 and GIP receptors
Clinically proven approach with personalized medical supervision No hidden fees or surprise charges
US$ 21.84
US$ 26.30
US$ 22.68
US$ 22.69
US$ 23.44
US$ 28.25
US$ 23.75
